Abstract
Background Coronavirus disease (COVID-19) pandemic has severely strained healthcare systems globally. Community pharmacists remain vital health professionals with unique roles in responding to symptoms, supplying medicines, and providing health promotion in the communities where they serve. The purpose of this study was to assess the level of knowledge and preparedness of community pharmacists in Zambia as frontline workers in curbing COVID-19.
Method This descriptive cross-sectional survey was conducted among 300 registered community pharmacists in Zambia. A self-administered online questionnaire was used to collect the data. Descriptive statistics were used to analyse the data using the Statistical Package for Social Sciences version 23.
Results From a total of 393 community pharmacists, 300 participated in the study indicating a response rate of 76.3%. 97% of the pharmacists knew the common signs and symptoms of COVID-19, 83% knew the national guidelines for screening criteria, and 93% were aware that a suspected case of COVID-19 presenting to the community pharmacy needed to be alerted to the national response team. Only 59% knew they needed to self-isolate and self-report should they experience symptoms of COVID-19. 85% stated that personal protective equipment was inadequate in the pharmacies they operated from. 60% of the pharmacists were prepared to participate in the frontline fight against COVID-19.
Conclusion Community pharmacists in Zambia are knowledgeable about COVID-19 signs and symptoms, including the technical guidelines on the screening and detection of suspected cases. Community pharmacists are prepared to participate in the frontline fight against the COVID-19 pandemic in Zambia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We received no external funding for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted by the University of Zambia Health Sciences Research Ethics Committee (UNZAHSREC) with an Ethics Approval of Protocol ID Number 20203101007.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Mpande Mukumbwa Mwenechanya: Email address: mpande.mwenechanya{at}cidrz.org
Steward Mudenda: Email address: freshsteward{at}gmail.com
Aubrey Chichoni Kalungia: Email address: ckalungia{at}unza.zm
Data Availability
Data is available in case other scholars want to use it
